Dr. Sean Michael Demars, MD

Dr. Demars practices at Kadlec Regional Medical Center in Richland, Washington, part of Providence Health & Services.

Dr. Demars' NPI, 1841261492, was assigned on January 31, 2006. Dr. Demars graduated from UVA School of Medicine in 2003. Dr. Demars' Washington license number on file is MD61139453.

Dr. Demars' primary practice is Kadlec Regional Medical Center, at 888 Swift Blvd, Richland, WA 99352 in Benton County. The practice phone is (509) 946-4611.

Dr. Demars' primary practice is Kadlec Regional Medical Center in Richland, Washington, part of Providence Health & Services. The medical group on file is Kadlec Regional Medical Center. Dmand AI also links Dr. Demars to 2 more group practices and clinics, 1 clinical lab and 1 medical group, each named with a free account. Dr. Demars' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Demars practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Demars' primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Demars is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Demars' licenses on file in 4 states: Washington, Montana, Wyoming and Nebraska.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Demars treats.

CMS data shows 666 Medicare services from Dr. Demars across 11 procedure codes in 2024, for 293 Medicare patients. Medicare paid $37,510 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 293 Medicare patients who saw Dr. Demars in 2024. The largest group is 65 to 74, with 130 patients. 67% of them have high cholesterol, and 63% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Demars' median patient age at 63, with 54% women.

In 2024, Dr. Demars wrote 349 Medicare Part D claims for 142 patients. 99% of them were for generic drugs. CMS names the drug for 238 of them, across 6 drugs with 11 or more claims each, at $3,858 in total drug cost. In 2023, CMS named 192 claims across 7 drugs.

Dr. Demars accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Demars. Dr. Demars' most frequent co-authors are Brian James Baumgartner, MD and James Vincent Crawford, MD.

CMS Open Payments shows 79 general payments to Dr. Demars from 13 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 71% of the total. Intersect ENT, Inc. paid the most, $2,814.

Dr. Demars graduated from UVA School of Medicine in 2003. Dr. Demars is a member of NHS.

Dr. Demars is in network with 12 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.